Skip to content

Sutureless Hemorrhoidectomy Versus Conventional Ligation in Advanced Hemorrhoids

Sutureless Hemorrhoidectomy Versus Conventional Ligation: A Comparative Prospective Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824999
Enrollment
50
Registered
2026-09-17
Start date
2026-10-01
Completion date
2027-10-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Keywords

Sutureless hemorrhoidectomy, LigaSure, Harmonic Scalpel, Milligan-Morgan, Postoperative pain

Brief summary

Hemorrhoidal disease is a frequent benign anorectal ailment in surgical practice. Conventional excisional hemorrhoidectomy using the Milligan-Morgan technique remains effective but is significantly limited by severe postoperative pain and related complications. Sutureless hemorrhoidectomy utilizing energy-based vessel sealing devices (such as LigaSure or Harmonic Scalpel) aims to minimize tissue trauma, blood loss, and postoperative discomfort. This prospective comparative randomized clinical trial aims to evaluate and compare the perioperative and postoperative outcomes of sutureless hemorrhoidectomy versus conventional ligation hemorrhoidectomy in adult patients with advanced (grades III and IV) hemorrhoidal disease.

Detailed description

Symptomatic advanced hemorrhoids (grades III-IV) frequently require excisional surgical intervention. Traditional ligation techniques involve pedicle transfixion that often exacerbates postoperative pain, anal spasms, and urinary retention. Energy-based vessel sealing systems provide reliable pedicle occlusion without conventional transfixion or suture ligation, potentially expediting operative time and recovery. In this prospective randomized study conducted at the Department of General Surgery, Sohag University Hospital, 50 eligible adult patients with symptomatic grade III-IV hemorrhoidal disease will be randomly allocated (1:1) into two equal groups: Group A (n=25): Sutureless hemorrhoidectomy using an energy-based vessel sealing device. Group B (n=25): Conventional ligation hemorrhoidectomy using the standard Milligan-Morgan technique. Postoperatively, patients receive standardized analgesia and care, with systematic follow-up at 1 week, 2 weeks, 1 month, 3 months, and 6 months to evaluate pain scores, bleeding, wound healing, complication rates, return to normal activity, and symptom recurrence.

Interventions

PROCEDUREEnergy-based sutureless hemorrhoidectomy

Excision of hemorrhoidal columns with vessel pedicle sealing using an energy-based device (LigaSure or Harmonic Scalpel) without conventional pedicle transfixion or suture ligation.

Standard Milligan-Morgan hemorrhoidectomy with surgical dissection of hemorrhoidal columns and absorbable suture transfixion and ligation of vascular pedicles.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients aged 18 years or older. * Patients with symptomatic grade III or grade IV hemorrhoidal disease. * Combined internal and external hemorrhoidal disease requiring excisional hemorrhoidectomy. * Recurrent bleeding, prolapse, pain, mucous discharge, or hygiene difficulty despite conservative or office-based treatment.

Exclusion criteria

* Patients younger than 18 years. * Grade I or grade II hemorrhoids suitable for conservative or office-based therapy. * Acute thrombosed external hemorrhoids requiring emergency management. * Associated anal fissure, fistula-in-ano, perianal abscess, or inflammatory bowel disease. * Suspected or confirmed colorectal malignancy\[cite: 1\]. * History of previous anorectal surgery\[cite: 1\]. * Bleeding diathesis, uncontrolled anticoagulant therapy, or severe coagulopathy\[cite: 1\].

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain ScoreUp to 6 months post-surgeryAssessed using the Visual Analogue Scale (VAS) scored from 0 (no pain) to 10 (worst imaginable pain) at fixed postoperative intervals.
Incidence of Postoperative BleedingUp to 6 months post-surgeryEvaluation of early or delayed postoperative perianal bleeding requiring intervention or readmission.

Secondary

MeasureTime frameDescription
Operative TimeIntraoperative (at time of surgery)Duration in minutes from the initiation of tissue excision to complete surgical hemostasis.
Intraoperative Blood LossIntraoperative (at time of surgery)Estimated intraoperative blood loss measured in milliliters.
Total Postoperative Analgesic RequirementUp to 6 months post-surgeryTotal analgesic dosage, type, and duration required for postoperative pain management.
Time to Complete Wound HealingAssessed at 1 week, 2 weeks, 1 month, 3 months, and 6 monthsClinical assessment of complete re-epithelialization of the anal wounds documented in weeks/months.
Length of Hospital StayFrom surgical admission up to discharge (average 1-2 days)Duration of postoperative stay in hours/days from operation until fulfilling discharge criteria.
Time to Return to Normal ActivityUp to 6 months post-surgeryRecorded in days from surgery until the patient comfortably resumes routine daily non-strenuous activities.
Rate of Postoperative Complications and RecurrenceUp to 6 months post-surgeryIncidence of urinary retention, wound infection, anal stenosis, continence disturbance, or symptom recurrence.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026